Dermatomyositis Completed Phase 2 Trials for Corticotropin (DB01285)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01906372Acthar in Treatment of Refractory Dermatomyositis and PolymyositisTreatment